Breakthrough in Leukemia Treatment
The fight against acute leukemia has taken a monumental leap forward with the U.S. Food and Drug Administration’s (FDA) approval of Revumenib (Revuforj)—a first-in-class treatment. ... Read More
Have any questions? call us
